Pennantpark Investme (PNNT) 7.97 $PNNT Uptrend Call

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pennantpark Investme (PNNT) 7.97 $PNNT

Uptrend Call Working As PennantPark Investment Stock Rises 29.4% (PNNT)
Comtex SmarTrend(R) - Fri Aug 26, 12:25AM CDT
SmarTrend identified an Uptrend for PennantPark Investment (NASDAQ NNT) on March 1st, 2016 at $5.89. In approximately 6 months, PennantPark Investment has returned 29.37% as of today's recent price of $7.62.
PNNT: 7.97 (+0.01)

28.9% Return Seen to Date on SmarTrend PennantPark Investment Call (PNNT)
Comtex SmarTrend(R) - Thu Aug 11, 12:27AM CDT
SmarTrend identified an Uptrend for PennantPark Investment (NASDAQ NNT) on March 1st, 2016 at $5.89. In approximately 5 months, PennantPark Investment has returned 28.86% as of today's recent price of $7.59.
PNNT: 7.97 (+0.01)

PennantPark Investment Corporation Announces Financial Results for the Quarter Ended June 30, 2016
Marketwire Canada - Mon Aug 08, 3:05PM CDT
NEW YORK, NY--(Marketwired - Aug 8, 2016) - PennantPark Investment Corporation (NASDAQ: PNNT) announces financial results for the third fiscal quarter ended June 30, 2016.
PNNT: 7.97 (+0.01)

PennantPark Investment Shares Up 24.4% Since SmarTrend's Buy Recommendation (PNNT)
Comtex SmarTrend(R) - Wed Aug 03, 1:11PM CDT
SmarTrend identified an Uptrend for PennantPark Investment (NASDAQ NNT) on March 1st, 2016 at $5.89. In approximately 5 months, PennantPark Investment has returned 24.45% as of today's recent price of $7.33.
PNNT: 7.97 (+0.01)

Downgrade Alert for PennantPark Investment (PNNT)
Comtex SmarTrend(R) - Thu Jul 28, 3:11AM CDT
PennantPark Investment (NASDAQ NNT) was downgraded from Buy to Neutral at DA Davidson today. The stock closed yesterday at $7.34 on volume of 478,000 shares, above average daily volume of 278,000. In the past 52 weeks, PennantPark Investment share prices have been bracketed by a low of $4.65 and a high of $9.72 and closed yesterday at $7.34, 58% above that low price. The 200-day and 50-day moving averages have moved 0.71% lower and 0.93% higher over the past week, respectively.
PNNT: 7.97 (+0.01)

PennantPark Investment Corporation Announces Quarterly Distribution of $0.28 per Share
Marketwired - Thu Jun 02, 3:05PM CDT
NEW YORK, NY--(Marketwired - Jun 2, 2016) - PennantPark Investment Corporation (the "Company" (NASDAQ: PNNT) declares third fiscal quarter 2016 distribution of $0.28 per share, payable on July 1, 2016 to stockholders of record as of June 20, 2016. Distributions are paid from taxable earnings and may include a return of capital and/or capital gains. The specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year and in the Company's periodic report filed with the Securities and Exchange Commission.
PNNT: 7.97 (+0.01)

PennantPark Investment Corporation Announces Financial Results for the Quarter Ended March 31, 2016
Marketwire Canada - Wed May 04, 3:05PM CDT
NEW YORK, NY--(Marketwired - May 4, 2016) -  PennantPark Investment Corporation (NASDAQ: PNNT) announced today financial results for the second fiscal quarter ended March 31, 2016.
PNNT: 7.97 (+0.01)

PennantPark Investment Corporation Schedules Earnings Release of Second Fiscal Quarter 2016 Results
Marketwired - Tue Apr 05, 3:12PM CDT
PennantPark Investment Corporation (the "Company" (NASDAQ: PNNT) announced that it will report results for the second fiscal quarter ended March 31, 2016 on Wednesday, May 4, 2016 after the close of the financial markets.
PNNT: 7.97 (+0.01)

PennantPark Investment Has Returned 16.7% Since SmarTrend Recommendation (PNNT)
Comtex SmarTrend(R) - Tue Feb 09, 10:35AM CST
SmarTrend identified a Downtrend for PennantPark Investment (NASDAQ NNT) on December 11th, 2015 at $6.37. In approximately 2 months, PennantPark Investment has returned 16.73% as of today's recent price of $5.30.
PNNT: 7.97 (+0.01)

Instant Analysis: PennantPark Hit By Energy Investments
Jordan Wathen, The Motley Fool - Motley Fool - Thu Feb 04, 11:05AM CST
What happened? PennantPark Investment just reported fourth-quarter earnings, kicking off a busy February of earnings reports for business development companies. In a sign that the quarter didn't exactly knock out the lights, the company announced...
PNNT: 7.97 (+0.01)

PennantPark Investment Corporation Announces Financial Results for the Quarter Ended December 31, 2015 and a Fee Waiver
Marketwired - Wed Feb 03, 3:05PM CST
PennantPark Investment Corporation (NASDAQ: PNNT) announced today financial results for the first fiscal quarter ended December 31, 2015 and a management fee waiver.
PNNT: 7.97 (+0.01)

The Bear Case for Apollo Investment and PennantPark Investment
Jordan Wathen, The Motley Fool - Motley Fool - Wed Feb 03, 12:09PM CST
Credit-rating agency Fitch laid out the succinct bear case for Apollo Investment and PennantPark Investment in a recent note to investors. "Leverage ratios for these two firms are the most affected from an oil and gas write-off scenario, with...
PNNT: 7.97 (+0.01), AINV: 6.13 (-0.06)

PennantPark Investment Shares Down 19.2% Since SmarTrend's Sell Call (PNNT)
Comtex SmarTrend(R) - Fri Jan 22, 11:52AM CST
SmarTrend identified a Downtrend for PennantPark Investment (NASDAQ NNT) on December 11th, 2015 at $6.37. In approximately 1 month, PennantPark Investment has returned 19.25% as of today's recent price of $5.14.
PNNT: 7.97 (+0.01)

Financial Sector Equities Under the Scanner -- Encore Capital Group, Western Asset Mortgage Capital, PennantPark Investment, and Moneygram Intl.
ACCESSWIRE - Fri Jan 15, 7:01AM CST
NEW YORK, NY / ACCESSWIRE / January 15, 2016 / Park Lane Advisor has initiated coverage on the following equities: Encore Capital Group Inc. (NASDAQ: ECPG), Western Asset Mortgage Capital Corporation (NYSE: WMC), PennantPark Investment Corporation (NASDAQ: PNNT), and Moneygram International Inc. (NASDAQ: MGI). Free research report on Encore Capital Group can be accessed at http://www.parklaneadvisor.com/ On Thursday, January 14, 2016, the NASDAQ Composite ended at 4,615.00, up 1.97%, the Dow Jones Industrial Average advanced 1.41%, to finish the day at 16,379.05, and the S&P 500 closed at 1,921.84, up 1.67%. The gains were broad based as all the sectors ended the session in positive. Register for your complimentary reports at the links given below.
MGI: 7.27 (-0.13), ECPG: 21.56 (-0.03), PNNT: 7.97 (+0.01), WMC: 10.58 (-0.02)

PennantPark Investment Corporation Schedules Earnings Release of First Fiscal Quarter 2016 Results
Marketwired - Fri Jan 08, 3:35PM CST
PennantPark Investment Corporation (the "Company" (NASDAQ: PNNT) announced that it will report results for the first fiscal quarter ended December 31, 2015 on Wednesday, February 3, 2016 after the close of the financial markets.
PNNT: 7.97 (+0.01)

Financial Sector Equities Coverage -- PennantPark Investment, Dynex Capital, Apollo Residential Mortgage, and United Development Funding IV
ACCESSWIRE - Fri Jan 08, 7:03AM CST
NEW YORK, NY / ACCESSWIRE / January 8, 2016 / Park Lane Advisor has initiated coverage on the following equities: PennantPark Investment Corporation (NASDAQ: PNNT), Dynex Capital Inc. (NYSE: DX), Apollo Residential Mortgage Inc. (NYSE: AMTG), and United Development Funding IV (NASDAQ: UDF). Free research report on PennantPark Investment can be accessed at http://www.parklaneadvisor.com/ On Thursday, December 07, 2016, the NASDAQ Composite ended at 4,689.43, down 3.03%, the Dow Jones Industrial Average declined 2.32%, to finish the day at 16,514.10, and the S&P 500 closed at 1,943.09, down 2.37%. The losses were broad based as all the sectors ended the session in negative. Register for your complimentary reports at the links given below.
PNNT: 7.97 (+0.01), UDF: 3.20 (-3.85), DX: 7.35 (-0.01), AMTG: 13.64 (+0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elite Robots Expands Global Reach with Mobile Manipulators

Updated Category News Views 105

Robots Hitting the Road? Picture this: robots that aren't just bolted to a factory floor but roam the production lines like tireless workers on wheels. That's what Elite Robots is betting on with their shiny new ELITEMISSION mobile manipulators. Not Just Any Old Robot These bad boys combine a robotic arm with an autonomous mobile platform. Think of an octopus getting off...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 228

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 13

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 147

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 29

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 28

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading
ICEYE Launches Gen5 SAR Satellite for Unrivaled Clarity

Updated Category News Views 60

Well, if you've been sleeping under a rock and missed the news, ICEYE just dropped another bombshell in the satellite biz. Gen5 is the name of the game, and it's claiming the spotlight for its razor-sharp imaging prowess. Now, we're talking about a satellite that supposedly snaps pictures with a resolution as fine as 11 cm. That's like spotting a flea on a dog's back from...

Continue Reading
Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 47

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading
2GenPen's Patent Push: Transforming Credit Analysis

Updated Category News Views 7

Changing the Game in Credit Analysis When you hear about a company snagging a patent, it's usually a big whoop-de-do; but 2GenPen's latest achievement is making some serious waves. This isn't some 'pat-yourself-on-the-back' sort of news – it's got teeth in the world of finance. These folks just locked down their second U.S. patent, number 12,784,096, and it's all about...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 131

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Innovation: Schneider Electric's Climate Tech Event

Updated Category News Views 170

Exploring the Excitement of the Climate Tech in the City Event The Climate Tech in the City event embodies the spirit of innovation, uniting key players in the climate technology sector. Leading organizations like Schneider Electric are at the forefront, showcasing groundbreaking advancements and sustainable practices. This year's gathering promises a vibrant day filled...

Continue Reading
Ouster Transforms Chattanooga into a Smart Traffic Hub

Updated Category News Views 404

Ouster's Groundbreaking Initiative in Smart Traffic Management In a significant development for urban traffic management, Ouster, Inc. (NASDAQ: OUST), recognized for its state-of-the-art lidar sensors, has launched a transformative project in Chattanooga. This venture stands out as the largest lidar-enabled traffic system in the United States, boasting a remarkable...

Continue Reading
Bicara Therapeutics Business Highlights and Q1 2025 Financial Review

Updated Category News Views 520

Bicara Therapeutics Announces Key Developments and Q1 2025 Financial Results Latest data from ongoing clinical trials to be showcased at upcoming conferences. Strong financial position enables sustained development through 2029. Bicara Therapeutics Inc. (Nasdaq: BCAX), a pioneering clinical-stage biopharmaceutical firm, focuses on delivering groundbreaking bifunctional...

Continue Reading
IO Biotech Gears Up for December Conferences: Insights and Highlights

Updated Category News Views 148

IO Biotech Prepares for Key Investor Conferences IO Biotech, a trailblazer in developing groundbreaking immune-modulatory cancer vaccines, is set to join two prominent investor events this December. The company, listed under NASDAQ: IOBT, is known for its innovative approach in the biopharmaceutical industry, particularly in creating off-the-shelf therapeutic cancer...

Continue Reading
Cardinal Energy Secures $40 Million Through Latest Debenture Offering

Updated Category News Views 267

Cardinal Energy Ltd. Announces a Major Offering Cardinal Energy Ltd. is excited to inform investors about its latest initiative aimed at raising funds through a significant offering. The company has entered into an agreement with a selected group of underwriters who will help facilitate the sale of $40 million in senior subordinated unsecured debentures. This strategic...

Continue Reading